Vimarsana
Biggest News Aggregation in the World

Page 2 - Allarity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allarity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allarity Today - Breaking & Trending Today

Allarity Therapeutics, Inc.: Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) - Vimarsana News

Allarity Therapeutics, Inc.: Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

Cambridge, MA U.S.A. (April 22, 2022) - Allarity Therapeutics, Inc. (Nasdaq: ALLR) ("Allarity" or the "Company"), a clinical-stage pharmaceutical company developing novel oncology therapeutics together

Nasdaq Stockholm AB: Delisting of Allarity Therapeutics A/S from Nasdaq First North Growth Market (668/21) - Vimarsana News

Nasdaq Stockholm AB: Delisting of Allarity Therapeutics A/S from Nasdaq First North Growth Market (668/21)

Allarity Therapeutics A/S has applied for its shares to be delisted from Nasdaq First North Growth Market. Nasdaq Stockholm AB has approved the application and decided to delist the shares in Allarity

Allarity Therapeutics A/S: Allarity Therapeutics Presents Dovitinib Survival Data from DRP Screened RCC Patients at ESMO 2021 Virtual Congress - Vimarsana News

Allarity Therapeutics A/S: Allarity Therapeutics Presents Dovitinib Survival Data from DRP Screened RCC Patients at ESMO 2021 Virtual Congress

Patient selection using DRP score of 50% resulted in a median survival of 15.0 monthPatient selection using DRP score of 67% resulted in a median survival of 20.6 months Press Release Hørsholm

Allarity Therapeutics A/S : Announces Extraordinary Exercise Period for Warrants of Series ALLR TO 3 Set to August 30 – September 13, 2021 - Vimarsana News

Allarity Therapeutics A/S : Announces Extraordinary Exercise Period for Warrants of Series ALLR TO 3 Set to August 30 – September 13, 2021

Press Release Hørsholm, Denmark – Allarity Therapeutics A/S today announces that an accelerated extraordinary and final exercise period for warrants of the ALLR TO 3 series , which... | August 27, 2021

Nasdaq Stockholm AB: The observation status for Allarity Therapeutics A/S updated (279/21) - Vimarsana News

Nasdaq Stockholm AB: The observation status for Allarity Therapeutics A/S updated (279/21)

On April 3, 2020, the shares in Allarity Therapeutics A/S (the "Company") (formerly known as Oncology Venture A/S) were given observation status with reference to a material adverse uncertainty in respect